L. Loreggian

910 total citations
21 papers, 354 citations indexed

About

L. Loreggian is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, L. Loreggian has authored 21 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Otorhinolaryngology, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in L. Loreggian's work include Head and Neck Cancer Studies (9 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Cancer Diagnosis and Treatment (5 papers). L. Loreggian is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Cancer Diagnosis and Treatment (5 papers). L. Loreggian collaborates with scholars based in Italy, United States and Egypt. L. Loreggian's co-authors include L. Tomio, Alessandro Gava, Carlo A. Mione, Maria Grazia Ghi, A. Paccagnella, Alberto Buffoli, H. Koussis, Andrea Bonetti, Adriano Paccagnella and Giovanni Pappagallo and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

L. Loreggian

20 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Loreggian Italy 7 278 228 142 122 32 21 354
Tod W. Speer United States 5 348 1.3× 302 1.3× 130 0.9× 124 1.0× 17 0.5× 10 432
B.S. Glisson United States 7 258 0.9× 173 0.8× 169 1.2× 166 1.4× 47 1.5× 10 357
Luciana Lastrucci Italy 9 250 0.9× 131 0.6× 111 0.8× 179 1.5× 38 1.2× 12 344
Christian Sire France 11 224 0.8× 108 0.5× 191 1.3× 124 1.0× 34 1.1× 21 329
Vamshi Muddu India 8 154 0.6× 107 0.5× 104 0.7× 59 0.5× 21 0.7× 19 239
R. Cavagnini Italy 3 163 0.6× 77 0.3× 74 0.5× 125 1.0× 25 0.8× 5 212
Laura Hargreaves United Kingdom 6 176 0.6× 68 0.3× 197 1.4× 188 1.5× 85 2.7× 9 336
M. A. Carroll United States 7 389 1.4× 334 1.5× 184 1.3× 170 1.4× 30 0.9× 11 482
F. Rosen United States 6 314 1.1× 219 1.0× 152 1.1× 118 1.0× 58 1.8× 10 399
Caitlin McMullen United States 10 108 0.4× 154 0.7× 92 0.6× 41 0.3× 24 0.8× 23 248

Countries citing papers authored by L. Loreggian

Since Specialization
Citations

This map shows the geographic impact of L. Loreggian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Loreggian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Loreggian more than expected).

Fields of papers citing papers by L. Loreggian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Loreggian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Loreggian. The network helps show where L. Loreggian may publish in the future.

Co-authorship network of co-authors of L. Loreggian

This figure shows the co-authorship network connecting the top 25 collaborators of L. Loreggian. A scholar is included among the top collaborators of L. Loreggian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Loreggian. L. Loreggian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loretelli, Cristian, Ida Pastore, Maria Elena Lunati, et al.. (2023). eATP and autoimmune diabetes. Pharmacological Research. 190. 106709–106709. 6 indexed citations
2.
Rolando, Maurizio, L. Loreggian, Sara Marini, et al.. (2023). Long-Term Activity and Safety of a Low-Dose Hydrocortisone Tear Substitute in Patients with Dry Eye Disease. Current Eye Research. 48(9). 799–804. 6 indexed citations
4.
Barabino, Stefano, L. Loreggian, Sara Marini, et al.. (2021). Efficacy of a New Tear Substitute Containing Hyaluronic Acid and a Low Dose of Hydrocortisone in Dry Eye Disease. 62(8). 1253–1253. 1 indexed citations
5.
Cazzola, Roberta, et al.. (2018). First insights of macadamia nut oil as dietary fat : Potential health benefits. 29(6). 18–20. 2 indexed citations
6.
Pontiroli, Antonio E., L. Loreggian, L. Folini, et al.. (2017). Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients. Biomarker Research. 5(1). 13–13. 7 indexed citations
8.
9.
Buffoli, Alberto, L. Loreggian, Alessandro Gava, et al.. (2006). 1107. International Journal of Radiation Oncology*Biology*Physics. 66(3). S192–S192. 1 indexed citations
10.
Rea, Federico, Giuseppe Marulli, Luigi Bortolotti, et al.. (2006). 180 Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): A single center experience. Lung Cancer. 54. S44–S44. 2 indexed citations
11.
Paccagnella, A., Alberto Buffoli, H. Koussis, et al.. (2006). Randomized phase II trial of concomitant CT/RT versus TPF followed by concomitant CT/RT in locally advanced squamous cell carcinoma of the head and neck (LASCCHN). Journal of Clinical Oncology. 24(18_suppl). 5518–5518. 12 indexed citations
12.
Paccagnella, A., G Cavaniglia, L. Loreggian, et al.. (2004). Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up. JNCI Journal of the National Cancer Institute. 96(22). 1714–1717. 143 indexed citations
13.
Loreggian, L., A. Paccagnella, Alessandro Gava, et al.. (2004). Randomized phase III trial of neoadjuvant chemotherapy (CT) in head and neck (H&N) cancer patients: An update based on 10 years' follow up. Journal of Clinical Oncology. 22(14_suppl). 5532–5532. 3 indexed citations
14.
Loreggian, L., A. Paccagnella, Alessandro Gava, et al.. (2004). Randomized phase III trial of neoadjuvant chemotherapy (CT) in head and neck (H&N) cancer patients: An update based on 10 years' follow up. Journal of Clinical Oncology. 22(14_suppl). 5532–5532. 3 indexed citations
15.
Loreggian, L., et al.. (1999). Radiation therapy in elderly patients with head and neck cancer: Preliminary results. 24. 44–48. 1 indexed citations
16.
Tomio, L., Mario Romano, G Zanchin, et al.. (1998). Ultrarapid high-dose course of prophylactic cranial irradiation in small cell lung cancer.. American Journal of Clinical Oncology. 84–90. 1 indexed citations
17.
Tomio, L., Maurizio Romano, Cristiana Carollo, et al.. (1998). Ultrarapid High-Dose Course of Prophylactic Cranial Irradiation in Small-Cell Lung Cancer. American Journal of Clinical Oncology. 21(1). 84–90. 9 indexed citations
18.
Loreggian, L., et al.. (1997). Chemo-radiotherapy in the elderly and/or poor performance status patients with advanced head and neck cancer. Radiology and Oncology. 31(2). 168–170. 1 indexed citations
19.
Favaretto, Adolfo, Adriano Paccagnella, L. Tomio, et al.. (1996). Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. feasibility, toxicity and long-term results of a phase II study. European Journal of Cancer. 32(12). 2064–2069. 12 indexed citations
20.
Loreggian, L., et al.. (1991). [Neoplasms of the gallbladder and the extrahepatic bile ducts: radio-chemotherapeutic combined treatment. Results in 18 treated cases].. PubMed. 81(5). 714–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026